Payables and Accruals [Abstract] Accrued expenses and other current liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Shares outstanding, Beginning Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Shares granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Shares exercised (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Shares forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Shares expired (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Shares outstanding, Ending Balance (shares) Shares exercisable (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Shares vested or expected to vest (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Weighted-Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Shares outstanding, weighted-average exercise price, Beginning Balance (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Shares granted, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Shares exercised, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Shares forfeited, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Shares expired, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Shares outstanding, weighted-average exercise price, Ending Balance (in usd per share) Shares exercisable, weighted-average exercise price (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Shares vested or expected to vest, weighted-average exercise price (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding, weighted-average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Exercisable, weighted-average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Vested or expected to vest, weighted-average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Outstanding, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Exercisable, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Vested or expected to vest, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Net product revenue Product [Member] Other revenue Product and Service, Other [Member] Statement [Line Items] Statement [Line Items] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Costs and expenses: Operating Expenses [Abstract] Cost of product revenue Cost of Goods and Services Sold Research and development Research and Development Expense Selling, general and administrative General and Administrative Expense Total costs and expenses Operating Expenses Loss from operations Operating Income (Loss) Interest income, net Interest Income, Operating Net loss Net Income (Loss) Attributable to Parent Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net loss per share attributable to common stockholders - basic and diluted (in usd per share) Earnings Per Share, Basic and Diluted Weighted-average number of common shares outstanding — basic and diluted (shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Research and development Research and Development Expense [Member] Selling, general and administrative General and Administrative Expense [Member] Employee Service Share-Based Compensation Allocation of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Stock-based compensation expense Allocated Share-based Compensation Expense Income Tax Disclosure [Abstract] Income tax provision (benefit) Income Tax Expense (Benefit) Equity [Abstract] Common stock Stockholders' Equity Note Disclosure [Text Block] Income taxes Income Tax Disclosure [Text Block] Accounting Policies [Abstract] Advertising expense Advertising Expense New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Shipping and Handling Shipping and Handling [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Stock-based compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Cash and cash equivalents Cash Restricted cash Restricted Cash Cash, cash equivalents and restricted cash shown on the condensed consolidated statement of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast Scenario, Forecast [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Corporate Corporate, Non-Segment [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Consumer Operations Consumer Operations [Member] Consumer Operations [Member] Drug Development Drug Development [Member] Drug Development [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Selling, general and administrative Selling, General and Administrative Expenses [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee termination benefits Employee Severance [Member] One-time termination benefits One-time Termination Benefits [Member] Employee retention benefits Retention Benefits [Member] Retention Benefits [Member] Other Other Restructuring [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Accrued research and development expense Accrued Research And Development Expense, Current Accrued Research And Development Expense, Current Percentage decrease in company workforce Percentage Decrease in Company Workforce Percentage Decrease in Company Workforce Cash retention bonuses payable Cash Retention Bonuses Payable Cash Retention Bonuses Payable Cash retention bonuses payable upon change in control Cash Retention Bonuses Payable Upon Change in Control Cash Retention Bonuses Payable Upon Change in Control Cash retention bonuses payable upon employees in good standing Cash Retention Bonuses Payable Upon Employees in Good Standing Cash Retention Bonuses Payable Upon Employees in Good Standing Severance benefits payable upon change in control and termination without cause Severance Benefits Payable Upon Change in Control and Termination Without Cause Severance Benefits Payable Upon Change in Control and Termination Without Cause Restructuring charges Restructuring Charges Number of retained employees Number of Retained Employees Number of Retained Employees Restructuring charges to be incurred if change of control occurs Restructuring Charges Incurred Upon Change in Control Restructuring Charges Incurred Upon Change in Control Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Flex Pharma, Inc. 2014 Equity Incentive Plan Flex Pharma, Inc. 2014 Equity Incentive Plan [Member] Flex Pharma, Inc. 2014 Equity Incentive Plan [Member] 2015 Equity Incentive Plan Equity Incentive Plan 2015 [Member] Equity Incentive Plan 2015 [Member] Employee Stock Option, One-Year Post Termination Exercisability Employee Stock Option, One-Year Post Termination Exercisability [Member] Employee Stock Option, One-Year Post Termination Exercisability [Member] Employee Stock Option, Three-Year Post Termination Exercisability Employee Stock Option, Three-Year Post Termination Exercisability [Member] Employee Stock Option, Three-Year Post Termination Exercisability [Member] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Employee stock option Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares remaining available for grant of stock awards Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Stock options, vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock options, contractual term Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Unrecognized compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation cost, recognition period (in years) Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Stock options, post termination exercisability period Share-based Compensation Arrangement by Share-based Payment Award, Options, Post Termination Exercisability Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Post Termination Exercisability Period Number of options outstanding (in shares) Number of employees holding options Share-based Compensation Arrangement by Share-based Payment Award, Number of Employees Holding Options Share-based Compensation Arrangement by Share-based Payment Award, Number of Employees Holding Options Number of advisers holding options Share-based Compensation Arrangement by Share-based Payment Award, Number of Advisers Holding Options Share-based Compensation Arrangement by Share-based Payment Award, Number of Advisers Holding Options Stock options, post termination exercisability extended period Share-based Compensation Arrangement by Share-based Payment Award, Options, Post Termination Exercisability Extended Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Post Termination Exercisability Extended Period Number of stock options granted (in shares) Number of employees granted options Share-based Compensation Arrangement by Share-based Payment Award, Number of Employees Granted Options Share-based Compensation Arrangement by Share-based Payment Award, Number of Employees Granted Options Fair Value Disclosures [Abstract] Summary of Cash Equivalents and Marketable Securities Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Earnings Per Share [Abstract] Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] U.S. government agency securities US Government Agencies Debt Securities [Member] Commercial paper Commercial Paper [Member] Corporate debt securities Corporate Debt Securities [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Marketable securities: Marketable Securities [Abstract] Marketable securities Debt Securities, Available-for-sale Total assets Assets, Fair Value Disclosure Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Marketable securities Marketable Securities, Current Accounts receivable Accounts Receivable, Net, Current Inventory Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Total assets Assets Liabilities and stockholders' equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued Expenses And Other Current Liabilities Deferred revenue Contract with Customer, Liability, Current Deferred rent, current portion Deferred Rent Credit, Current Total current liabilities Liabilities, Current Deferred rent, net of current portion Deferred Rent Credit, Noncurrent Total liabilities Liabilities Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.0001 par value; 10,000,000 shares authorized at June 30, 2018 and December 31, 2017; none issued or outstanding at June 30, 2018 and December 31, 2017 Preferred Stock, Value, Issued Common stock, $0.0001 par value; 100,000,000 shares authorized at June 30, 2018 and December 31, 2017; 18,069,476 and 17,972,166 shares issued at June 30, 2018 and December 31, 2017, and 18,066,142 and 17,797,178 shares outstanding at June 30, 2018 and December 31, 2017, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders' equity Liabilities and Equity Phase 2 MND and CMT clinical trial-related costs Restructuring-related costs Restructuring Reserve, Current Payroll and other employee-related costs Employee-related Liabilities, Current Professional fees Accrued Professional Fees, Current Other research and development-related costs Accrued Research And Development Expense, Other, Current Accrued Research and Development Expense, Other, Current Consumer product-related costs Accrued Marketing Costs, Current Total Restricted stock Restricted Stock [Member] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Non-employee Consultants and Advisers Non-employee Consultants and Advisers [Member] Non-employee Consultants and Advisers [Member] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Beginning balance, unvested (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Issued (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Ending balance, unvested (shares) Weighted-Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning balance, weighted average grant date fair value (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Issued, weighted average grant date fair value (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested, weighted average grant date fair value (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited, weighted average grant date fair value (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Ending balance, weighted average grant date fair value (in usd per share) Document And Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Vesting [Axis] Vesting [Axis] Vesting [Domain] Vesting [Domain] Vests upon issuance Share-based Compensation Award, Tranche One [Member] Vests ratably over four years Share-based Compensation Award, Tranche Two [Member] Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Common stock, number of votes per share Common Stock, Number of Votes Number of Votes Restricted common stock, shares sold (shares) Stock Issued During Period, Shares, New Issues Restricted common stock, price per share (in usd per share) Sale of Stock, Price Per Share Proceeds from sale of restricted common stock to founders Proceeds From Sale Of Restricted Common Stock Proceeds From Sale Of Restricted Common Stock Restricted common stock, percent vested Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Restricted common stock, vesting period (in years) Restricted common stock, shares outstanding (shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Statement of Comprehensive Income [Abstract] Net loss Other comprehensive gain (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrealized gain (loss) on available-for-sale securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Inventory Disclosure [Abstract] Schedule of Inventory, Net Schedule of Inventory, Current [Table Text Block] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Opening balance Restructuring Reserve Charges: Payments Payments for Restructuring Accrued restructuring balance as of June 30, 2018 Raw materials Inventory, Raw Materials, Net of Reserves Finished goods Inventory, Work in Process, Net of Reserves Total inventory Write-off of inventory Inventory Write-down Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and operations Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Net loss per share Earnings Per Share [Text Block] Restricted common stock activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Segment Reporting [Abstract] Schedule of Information for the Company's Operating Segments Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Summary of stock option activity Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of stock-based compensation expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from contracts with customers Revenue from Contract with Customer [Text Block] Cash and Cash Equivalents [Abstract] Schedule of Marketable Securities Debt Securities, Available-for-sale [Table Text Block] Segment Information Segment Reporting Disclosure [Text Block] Cash equivalents and marketable securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Schedule of accrued expenses Schedule of Accrued Liabilities [Table Text Block] Schedule of other current liabilities Other Current Liabilities [Table Text Block] Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Fair value measurements Fair Value Disclosures [Text Block] Number of reportable segments Number of Reportable Segments Net loss Retained earnings (accumulated deficit) Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Inventory Inventory Disclosure [Text Block] Accounts receivable Receivables, Policy [Policy Text Block] Allowance for doubtful accounts Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Advertising expense Advertising Costs, Policy [Policy Text Block] Shipping and handling costs Revenue from Contract with Customer [Policy Text Block] Restructuring-related costs Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block] Basis of presentation Basis of Accounting, Policy [Policy Text Block] Use of estimates Use of Estimates, Policy [Policy Text Block] Principles of consolidation Consolidation, Policy [Policy Text Block] Recent accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Fair value measurements Fair Value Measurement, Policy [Policy Text Block] Cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Marketable securities Marketable Securities, Policy [Policy Text Block] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Difference between Revenue Guidance in Effect before and after Topic 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Increase to retained earnings due to adoption of Topic 606 Decrease in deferred revenue Contract with Customer, Liability Decrease in deferred costs from product revenue Deferred Costs Refund period Contract with Customer, Refund Period Contract with Customer, Refund Period Discounts to customers Sales Discounts Sales Discounts Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Options to purchase common stock Unvested restricted common stock Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Summary of significant accounting policies and recent accounting pronouncements Significant Accounting Policies [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Operating Segments Operating Segments [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Loss from operations Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Fair Value Number of debt securities in an unrealized loss position Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Aggregate fair value of debt securities in an unrealized loss position Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months Number of debt securities in a significant unrealized loss position Debt Securities, Available-for-sale, Significant Unrealized Loss Position, Number of Positions Debt Securities, Available-for-sale, Significant Unrealized Loss Position, Number of Positions Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation expense Depreciation Stock-based compensation expense Share-based Compensation Amortization and accretion on investments Investment Income, Net, Amortization of Discount and Premium Other non-cash items Other Noncash Income (Expense) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Other assets Increase (Decrease) in Other Noncurrent Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Deferred revenue Increase (Decrease) in Contract with Customer, Liability Deferred rent Increase (Decrease) in Deferred Liabilities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of marketable securities Payments to Acquire Marketable Securities Proceeds from maturities and sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from sales of property and equipment Proceeds from Sale of Property, Plant, and Equipment Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from exercise of common stock Proceeds from Stock Options Exercised Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Inventory purchases included in accounts payable and accrued expense at June 30, 2017 Inventory Purchases in Accounts Payable and Accrued Expense Inventory Purchases in Accounts Payable and Accrued Expense Property and equipment purchases included in accounts payable at June 30, 2017 Capital Expenditures Incurred but Not yet Paid Property and equipment purchases included in accounts payable and accrued expenses at December 31, 2016 Property And Equipment Purchases In Accrued Expense Property and Equipment Purchases In Accrued Expense